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Abstract — Chronic obstructive pulmonary disease is a 
growing health concern worldwide. Telehealth can 
facilitate integrated COPD care by providing an 
opportunity for remote monitoring, early diagnosis and 
clinical intervention. A design for a telehealth-based 
system called Wearable Sensing and Smart Cloud 
Computing for Integrated Care to COPD Patients with 
Co-morbidities (WELCOME) has been proposed. This 
study identifies patients’, informal carers’ and HCPs’ 
acceptance of and requirements for the WELCOME 
system in four European countries: the United Kingdom 
(UK), Ireland, Greece and Netherlands. 
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I.  INTRODUCTION  
COPD (Chronic Obstructive Pulmonary Disease) is a major 
chronic respiratory condition that affects millions of people 
worldwide and its prevalence is growing [1]. Treatment is 
complex, necessitates polypharmacy and a multidisciplinary 
team of healthcare professionals (HCPs) involved in patient 
care [2-3]. In addition, COPD is frequently accompanied by a 
number of co-morbidities: chronic heart failure [4], diabetes 
[5], anxiety and depression [6], all of which complicate the 
clinical management. 
Telehealth is a way to facilitate the care of such complex 
patients through provision of remote monitoring and 
facilitation of integrated care. Telehealth can be defined as 
remote monitoring of patient’s health by HCPs using mobile 
medical devices to support early diagnosis and prompt 
intervention. [7-8]. It has been shown that telehealth can lead to 
a reduction in mortality and length of hospitalisation in 
diabetes, heart failure and COPD [9]. 
WELCOME is an innovative telehealth system that 
proposes to develop a wearable vest with sensors for 
monitoring of a number of physiological signals, such as chest 
sounds, heart sounds, ECG, etc. Other measuring devices to be 
used as part of the Welcome system are: a blood glucose meter, 
weight scale, blood pressure machine and an inhaler 
monitoring device. This will be accompanied by a 
patient/carers support system that will address disease/medicine 
education, lifestyle advice, mental health assessment and 
coaching etc 
The aim of this study is to identify COPD stakeholders’ 
acceptance of and requirements for the WELCOME system in 
the UK, Ireland, Greece and Netherlands. The stakeholders 
were identified as patients, informal carers (family members or 
partners of patients who care for them) and all HCPs involved 
in their care 
II. METHOD 
This is a qualitative study conducted in the UK, Ireland, 
Greece and Netherlands between January and June 2014. This 
included focus groups with COPD patients and their carers and 
semi-structured interviews with all healthcare professionals 
involved in the care of these patients. 
The focus group schedules for patients and carers were 
designed to include the following sections: perception of 
current care, oral medicine/inhaler adherence, perception of 
technology, telehealth and the WELCOME system overall and 
its components.  
The interview schedule for healthcare professionals 
included sections on views about the current healthcare system 
and its challenges, perception about the WELCOME system 
and its components, monitoring parameters and their frequency 
etc. 
To facilitate Greek and Dutch data collection, the schedules 
were translated from English to Greek and Dutch respectively.  
Data collection was conducted by moderators over 2-hour 
focus groups with patients and carers separately and 1-hour 
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semi-structured interviews with HCPs. Those were recorded on 
digital voice recorders, and subsequently transcribed verbatim. 
The Dutch and Greek transcripts were translated into English. 
All transcripts were coded to identify recurring themes as part 
of a cross sectional thematic analysis. 
A. UK 
The UK focus groups and interviews were conducted at 
Croydon University Hospital. The former involved 10 COPD 
patients (1 patient with COPD alone, 2 with COPD and 
diabetes, 2 patients with COPD and heart disease, 5 with 
COPD and depression) in one group and 6 of their informal 
carers in another group. The interviews were conducted with 8 
HCPs (general medicine doctor, cardiologist, pulmonologist, 
diabetologist, 3 nurses and a physiotherapist). 
B. Greece 
In Greece, 3 focus groups were conducted with a total of 7 
patients (1 with COPD alone 2 with COPD and diabetes, 2 with 
COPD and anxiety or depression, 2 with COPD and congestive 
heart failure) and 7 informal carers. Four one-on-one semi-
structured interviews were conducted with 4 HCPs 
(cardiologist, pulmonologist, internal medicine 
specialist/diabetologist, and a psychiatrist). 
The participants were recruited from G. Papanikolaou 
General Hospital of Thessaloniki except for the Psychiatrist 
and the Cardiologist who work at the Psychiatric Hospital of 
Thessaloniki and the General Hospital of Naoussa respectively. 
C. Ireland 
In Ireland, the two focus groups involved 7 patients and 4 
informal carers in separate groups. The semi-structured 
interviews were conducted with 5 HCPs (pulmonologist, 
COPD specialist nurse, diabetologist, physiotherapist and a 
psychiatrist) 
The participants were recruited from Beaumont hospital in 
Dublin. 
D. Netherlands 
In the Netherlands, the two focus groups involved 8 
patients and 6 of their informal carers in two separate groups. 
The semi-structured interviews were conducted with 6 HCPs 
individually (pulmonologist, specialist nurse, dietician, 
physiotherapist, internist and a physician's assistant). 
The participants were recruited from CIRO+ (Centre for 
Expertise for Chronic Organ Failure) in Horn, Netherlands. 
 
III. RESULTS 
This cross sectional thematic analysis resulted in the 
following recurring themes across all stakeholders. 
A. Perception of the Current Care 
Across the four countries, all patients and carers 
complained that healthcare services for COPD patients are 
fragmented with limited communication between different 
HCPs involved in their care. Moreover, it was reported that 
patients face long waiting times before getting 
appointments/getting referred to specialists.  
 ‘I am staying at the village. I have to go to the health 
centre. This has to be done with an appointment. But 
it is now that I am in pain. What is the use if they 
book me an appointment for next week?’  
 ‘you don’t have the access [to medical care] you 
need when you need it’. 
Fragmentation of communication between HCPs was 
highlighted by Irish HCPs, as continuity of care and knowing 
what happens to patients on a day to day basis was described as 
a challenge in their work. 
Moreover, carers across the board expressed their 
frustration with having to make a judgment call about their 
patients’ health status when they are suffering from an 
exacerbation. They don’t always know when to call and seek 
help. 
B. Barriers for Optimal Care 
Lack of adherence was identified as a common theme. 
Some reasons behind this were forgetfulness, busy lifestyle, pill 
burden, concern over side effects, swallowing difficulty and 
health beliefs. The latter was reflected in some patients/carers 
who were concerned about 'over dosing on inhalers' and 
expressed their misconception about steroids and inhalers:  
 ’afraid they [inhalers] won’t work anymore’. 
Challenges with inhaler technique were also discussed, and 
some patients indicated that they had to use spacers or had to 
be changed from metered dose inhalers to dry powder inhalers.  
 ‘I have a problem how to use them technically. […] I 
don't know how to press and how to breathe. You 
have to breathe out at first and then to breathe in’. 
It was also evident that patients/carers don’t have enough 
information about the medicines, their side effects and how to 
prevent the latter. 
 ‘I take 6 inhalers. That doesn’t make any sense to me. 
Are they working together? Are they working against 
each other?’ 
 ‘I ended up with glaucoma from the inhalers, the 
nebulizers. Which nobody told me about. I could have 
been wearing protective glasses. […]. It’s from 
inhaling the steroids. They never told me’. 
In contrast, HCPs reported there is poor engagement by 
patients in their care and they were not sure how to encourage 
patients to better manage their medication and treatment of 
COPD. This is particularly an issue in light of the 
complications from complex treatment regimes. 
C. Acceptance of WELCOME system 
The WELCOME system was very well received by all 
stakeholders in all 4 countries.  
The patients/carers were very impressed and thought it was 
'brilliant and creative'. Overall they accepted all elements of the 
proposed system including the vest and inhaler monitoring 
device.  
 ‘I tend to wait too long before I ask for help because I 
feel I’m being a burden, bothering people. In that 
kind of situation Telehealth could be good. ‘ 
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There was little concern over security and confidentiality, 
as patients and carers felt that the benefit of such a system 
outweighs any concerns. 
The HCPs indicated it’ll be helpful for housebound patients 
and for avoiding hospitalizations through early detection. 
Moreover, they felt it will reduce the delay currently observed 
with patient seeking medical advice. Therefore the risk of 
hypotension, acute renal failure and hospitalization will be 
reduced. 
 ‘I do think for the right people it would be very useful 
because there are patients who, especially the house 
bound ..... It’s harder to do that to go out to see them.  
And also, we don’t do those clinics often enough as 
much as they may well need it. (..) So I think for, 
especially chosen patients, I think it would work 
really well.’ 
  ‘The usefulness will relate to keeping patients out of 
hospital who have recently been discharged following 
treatment of an exacerbation of heart failure in 
particular.....give more reliable data on the patient’s 
risk of readmission and whether further intervention 
is necessary to prevent that.’  
 
D. Stakeholder needs from the WELCOME system 
1) Vest Concerns: The main concern over the WELCOME 
system was the vest and its level of comfort (weight, materiel, 
tightness etc). However, this was not identified as a barrier. 
 ‘my health comes first. And I would wear it all the 
time if it’s going to help my health’ 
 ‘I think it is best to remove it during sleeping time. 
Unless there is a problem. It is good to also wear it at 
sleep, when the condition has worsened.’ 
Another concern came about from one carer whose patient 
has a pacemaker and was worried that the wireless signal in the 
vest might interfere with it. Moreover, patients/carers would 
like the vest to have an indicator to show whether the vest is 
working or not. 
2) Experience with Technology: It’s important to note that 
most patients/carers were not very comfortable with 
technology, and the use of smart devices was not part of their 
daily life. 
 ‘I believe that this is a very big step, but if it starts 
right now it will target people from a specific age 
group that are not familiar with technology. My 
father [age 75], for example, at this moment does not 
even know how to use a mobile phone. It will be very 
difficult for this to be done by people of his age.’ 
 
3) Access to monitoring data: Patients and Carers did not 
agree fully about who has access to the monitoring results. 
Carers were definitely interested in this data, however, some of 
the patients did not want to grant their carers access. However, 
they wanted all HCPs involved in their care-including their 
pharmacists- to be able to see their results. 
 
4) Feedback:It was agreed that patients should receive 
feedback/advice based on their results. Even if results are 
within normal limits, patients should still receive positive 
reinforcement.  
The type of advice/feedback generated in response to an 
abnormal result should factor patient’s mood. Therefore format 
of the feedback should be indivudualised. 
5) Customizable/individualized algorithms:The frequency 
and parameters to be monitored are to be individualised 
depending on patients’ symptoms and condition. Decisions 
regarding individualisation of parameters and the frequency of 
measurements should be set by patient’s HCPs collectively. 
In order to individualise the decision, the results should be 
compared to patients’ individual baseline (measurements taken 
when in best health) to determine results’ severity, instead of 
comparing to a set standard: 
 ‘Have a baseline measurement and from there to be 
able to make a comparison and then the classification 
as being a disorder or not.’  
IV. DISCUSSION AND CONCLUSION 
This analysis provides an in depth view into the current 
state of care for COPD patients with/without co-morbidities in 
the UK, Greece, Netherlands and Ireland along with how the 
proposed WELCOME project can be implemented to integrate 
care and improve patient outcomes. 
One of the important points raised by all cohorts in all 
countries centred on the challenges they face in the current 
healthcare system which included fragmented care, lack of 
communication and long waiting times to be seen by HCPs. 
This is also well documented in the literature and is seen as a 
cause for an increased readmission rate in COPD patients [12]. 
The WELCOME system promises to facilitate an integrated 
care model for these patients whereby all HCPs involved in the 
care of the same patient can communicate and have access to 
the same monitoring results (Figure1). 
The patients and carers were very receptive to telehealth 
and the WELCOME project, and they raised valuable points 
that need to be considered in the design, implementation and 
validation phases. This is also reflected in previous studies 
whereby COPD patients who experienced telehealth services 
were very satisfied with what telehealth provided in terms of 
emotional and medical support [10]. 
The only major perceived barrier to its implementation is 
the requirement for technical competence and operation of 
equipment. This was also identified in other studies such as the 
Whole System Demonstrator whereby some patients refused to 
participate in the study due to dislike of technology [11]. 
However, this will not be a long term issue as the patients of 
the future will be very comfortable with technology and the use 
of smart devices. For current telehealth use, this needs to be 
considered during patient recruitment as patient’s comfort with 
and acceptance of technology is imperative for the success of 
any intervention. 
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Another concern that was echoed by the patients and the 
carers was the comfort of the vest. Moreover, the schedule of 
self-monitoring (by the vest and other devices) should be 
flexible and not regimented so as not to interfere with daily 
activities 
Reported adherence was suboptimal with patients forgetting 
or choosing not to take their medicines as prescribed. Health 
beliefs are well documented in the literature and are known to 
influence adherence rates in COPD patients [13]. It was 
interesting to note that the patients never discuss these issues 
with their HCPs which led the latter to accuse their patients of 
being unengaged in their care. 
Besides monitoring physiological parameters, the 
WELCOME system will give patients access to educational 
functionalities regarding their disease, medicines and lifestyle. 
Moreover, the inhaler monitoring device will assist the HCPs 
in identifying low adherence and /or poor inhaler technique. 
The system will also provide feedback to the patients related to 
their results, and thus allow them to adjust their medicines / 
lifestyle accordingly before complications/deteriorations 
arise.The stakeholders were very receptive of such feedback as 
it will provide valuable support and will allow patients to have 
an active role in their treatment. 
 
Figure 1.  Sample Integration of telehealth into care pathway 
The design of the WELCOME system will take into 
consideration all the results of this analysis in an effort to 
produce a system that will integrate care from different HCPs 
while empowering patients to self-care.  
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